Literature DB >> 22926201

Capture, crawl, cross: the T cell code to breach the blood-brain barriers.

Britta Engelhardt1, Richard M Ransohoff.   

Abstract

The central nervous system (CNS) is an immunologically privileged site to which access of circulating immune cells is tightly controlled by the endothelial blood-brain barrier (BBB; see Glossary) localized in CNS microvessels, and the epithelial blood-cerebrospinal fluid barrier (BCSFB) within the choroid plexus. As a result of the specialized structure of the CNS barriers, immune cell entry into the CNS parenchyma involves two differently regulated steps: migration of immune cells across the BBB or BCSFB into the cerebrospinal fluid (CSF)-drained spaces of the CNS, followed by progression across the glia limitans into the CNS parenchyma. With a focus on multiple sclerosis (MS) and its animal models, this review summarizes the distinct molecular mechanisms required for immune cell migration across the different CNS barriers.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22926201     DOI: 10.1016/j.it.2012.07.004

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  233 in total

Review 1.  Factors controlling permeability of the blood-brain barrier.

Authors:  Mohammed M A Almutairi; Chen Gong; Yuexian G Xu; Yanzhong Chang; Honglian Shi
Journal:  Cell Mol Life Sci       Date:  2015-09-24       Impact factor: 9.261

Review 2.  Glial regulation of the blood-brain barrier in health and disease.

Authors:  Bieke Broux; Elizabeth Gowing; Alexandre Prat
Journal:  Semin Immunopathol       Date:  2015-08-06       Impact factor: 9.623

3.  A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.

Authors:  Uwe Reusch; Johannes Duell; Kristina Ellwanger; Carmen Herbrecht; Stefan Hj Knackmuss; Ivica Fucek; Markus Eser; Fionnuala McAleese; Vera Molkenthin; Fabrice Le Gall; Max Topp; Melvyn Little; Eugene A Zhukovsky
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 4.  Brain-peripheral cell crosstalk in white matter damage and repair.

Authors:  Kazuhide Hayakawa; Eng H Lo
Journal:  Biochim Biophys Acta       Date:  2015-08-13

5.  Drug delivery to melanoma brain metastases: Can current challenges lead to new opportunities?

Authors:  Gautham Gampa; Shruthi Vaidhyanathan; Jann N Sarkaria; William F Elmquist
Journal:  Pharmacol Res       Date:  2017-06-17       Impact factor: 7.658

6.  1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization.

Authors:  Inna V Grishkan; Amanda N Fairchild; Peter A Calabresi; Anne R Gocke
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

7.  ICAM-1null C57BL/6 Mice Are Not Protected from Experimental Ischemic Stroke.

Authors:  Gaby U Enzmann; Sofia Pavlidou; Markus Vaas; Jan Klohs; Britta Engelhardt
Journal:  Transl Stroke Res       Date:  2018-02-04       Impact factor: 6.829

Review 8.  Immune Cells After Ischemic Stroke Onset: Roles, Migration, and Target Intervention.

Authors:  Lu-Yao Ao; Yun-Yi Yan; Lin Zhou; Cheng-Yuan Li; Wan-Ting Li; Wei-Rong Fang; Yun-Man Li
Journal:  J Mol Neurosci       Date:  2018-10-01       Impact factor: 3.444

Review 9.  Cell-culture models of the blood-brain barrier.

Authors:  Yarong He; Yao Yao; Stella E Tsirka; Yu Cao
Journal:  Stroke       Date:  2014-06-17       Impact factor: 7.914

Review 10.  CD4 T cells in immunity and immunotherapy of Alzheimer's disease.

Authors:  Alon Monsonego; Anna Nemirovsky; Idan Harpaz
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.